
Sarine Beukian, AGACNP-BC, FHFSA
@SBeukian
Followers
395
Following
1K
Media
149
Statuses
1K
CCU ACNP @NYPCUCVI. #WomenInHF. By way of @AUB_Lebanon & @CWRU. Quadrilingual. Be honest, be bold. We only have one planet. Dix pages par jour. Views=own.
New York, NY
Joined June 2012
Hi, are you an APRN practicing in HF in the US? Please take a moment to participate in a study @nancy_m_albert and I are conducting. Once you scan the QR code, you will learn more about the study and eligibility. One more thing, please help us spread the word by 🔁
7
6
5
RT @SBeukian: Hi, are you an APRN practicing in HF in the US? Please take a moment to participate in a study @nancy_m_albert and I are cond….
0
6
0
@nancy_m_albert @megfrasernp @Steph_BarnesNP @DNPKleet @SusanSchnell @jhernandeznp @KismetRasmu @vkagan6 @Margie_Cuomo @nurseviveyanne @486mweaver @Christiana_DNP @JohanaFajardDNP @jeffgossHF @amanda_acnp @StephenNP @Amy_StiversNP @KristenAshNP @CCMNP @michellescotton @quin_denfeld @RuthMCreber.
0
0
1
Who's joining us for the Annual NP/ CRNA Summit!.My slides were done ahead of schedule - 2 weeks ago! .Registration-> October 22nd 8 am - 4 pm.#MedTwitter #NursePractitioner #CRNA #HeartFailure
0
0
5
ARIES-HM3 Trial Analysis by @JasonKatzMD .Is an ASA free regimen safe? outcomes aren't modified by the use of pharmacological therapy. @rcstarling provided expert analysis - 3 aspects to LVAD outcomes: human, machine & management. Trials are challenging, indeed. #HFSA2024 @HFSA
2
4
12
RT @m_keykhaei: 💡HELIOS-B delivered some real impact today with @MathewMaurer breaking down how Vutrisiran cuts all-cause mortality & CV ev….
0
3
0
RT @AlexaB_KahnMD: One of my favorite topics #Amyloid🫀analyses from HELIOS-B by @MathewMaurer.🔸VUTRISIRAN maintained stability of NT-proBNP….
0
1
0
RT @AlexaB_KahnMD: 🎨FINEARTS-HF - Efficacy & safety of FINERENONE in pt.’s w. HFmrEF or HFpEF presented by @akshaydesaimd . 🟪pt’s w. recent….
0
4
0